Featured Articles

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras vel sagittis libero, a lacinia nisi. Interdum et malesuada fames ac ante ipsum primis in faucibus. Donec nec nisl turpis. Pellentesque pretium pellentesque maximus. Nam efficitur massa justo, eget laoreet odio congue convallis. Proin sagittis mauris sit amet justo cursus, sit amet porta eros eleifend. Nullam felis tortor, pharetra a consequat eget, luctus non massa. Cras sed efficitur felis, sollicitudin gravida eros. Mauris congue efficitur tempor.

Renseigner une description via Articles > Categories > Featured Articles > Champ 'Description' pour remplacer ce Lorem ipsum.

Integrating Technology and Expertise

Featured Articles

Phase I/II study in cancer patients showcases eClinical effectiveness. An Article written by IDDI Published in Applied Clinical Trials, February…

Read more

Sample Size Re-Estimation as an Adaptive Design

Featured Articles

Using the promising-zone approach can salvage an underpowered trial. Sample size Re-estimation (SSRE) is a relatively new concept, but, thanks…

Read more

Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpoints

Featured Articles

Vaiva Deltuvaite-Thomas, Research Statistician, IDDI and Prof. Tomasz Burzykowski, VP Research IDDI have just published an article on operational characteristics…

Read more

Immunotherapy against cancer: Challenge and opportunities

Featured Articles

With some of the recently developed drugs showing unprecedented response rates and consistent improvement in overall survival in some indications,…

Read more

Drug Development in Oncology in the Era of Precision Medicine

Featured Articles

Cancer research is complex: trials require specific design expertise and often include biomarker and companion diagnostics, and failure rates tend…

Read more

The Importance of Early Phase Trials in Precision Oncology

Featured Articles

Nowadays, drug development in oncology is largely centered on the basic premise of precision medicine, according to which targeted agents…

Read more

Considerations on the mechanics and sample sizes for early trials of targeted agents and immunotherapy in oncology

Featured Articles

Read article on trial design and sample sizes for early trials Written by Elisabeth Coart and Everardo D. Saad, Consulting…

Read more

Clinical Development Trends

May 25, 2021

News & Events
Featured Articles

In addition to pharmaceutical and biopharmaceutical sponsors outsourcing clinical trials to Contract Research Organizations (CROs) to gain flexibility and speed…

Read more

Personalized Medicine: A Work in Progress

Featured Articles

Dr. Everardo Saad, Medical Director of IDDI contributed to an article on Personalized Medicine published in the June issue of…

Read more

Commanders & Chiefs: Clinical Services C-Suite – Pharmavoice

Featured Articles

IDDI contributed to the Pharmavoice article: Commanders & Chiefs: Clinical Services C-Suite, February, 2021 CROs and other clinical services companies…

Read more